Scandinavian ChemoTech updates on its most important milestone
The Company's focus on Human Care in the Indian market is proving to be successful. Our unique TSE technology aligns seamlessly with the healthcare landscape in India, addressing the significant challenges posed by head and neck cancer, which contributes to numerous fatalities and considerable suffering.While head and neck cancer pose a significant global challenge, India stands out as the country with the highest incidence and mortality rates (recording 200,000 new cases annually[1]). In October 2022, the clinical trial commenced at Jodhpur University Hospital in India. The trial's